The effect of a nutritional model of chronic liver injury on the hepatic glucuronidation of morphine in rats.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 7908047)

Published in J Pharm Pharmacol on November 01, 1993

Authors

R Callaghan1, P V Desmond, M L Mashford

Author Affiliations

1: Department of Clinical Pharmacology, St Vincent's Hospital, Fitzroy, Victoria, Australia.

Articles by these authors

Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B. Gut (2010) 2.37

Implementing clinical guidelines. It works in Australia. BMJ (1993) 2.25

Use of an overtube for enteroscopy--does it increase depth of insertion? A prospective study of enteroscopy with and without an overtube. Endoscopy (2001) 2.11

Improving the quality of antibiotic prescription patterns in general practice. The role of educational intervention. Med J Aust (1994) 2.02

Biopsy forceps is inadequate for the resection of diminutive polyps. Endoscopy (2011) 1.82

Alterations of food antigen-specific serum immunoglobulins G and E antibodies in patients with irritable bowel syndrome and functional dyspepsia. Clin Exp Allergy (2007) 1.74

Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology (1998) 1.70

Changing antibiotic prescribing by educational marketing. Med J Aust (1989) 1.70

Cimetidine impairs elimination of chlordiazepoxide (Librium) in man. Ann Intern Med (1980) 1.61

Risk factors and predictors of outcome in an Australian cohort with hepatitis C virus infection. Med J Aust (1995) 1.43

Postoperative recurrence of Crohn's disease: impact of endoscopic monitoring and treatment step-up. Colorectal Dis (2013) 1.42

Covert self poisoning with brodifacoum, a 'superwarfarin'. Aust N Z J Med (1990) 1.42

Impaired elimination of caffeine by oral contraceptive steroids. J Lab Clin Med (1980) 1.41

Achalasia of the oesophagus: treatments with pneumatic dilatation. J Gastroenterol Hepatol (1991) 1.40

Effects of aging and liver disease on disposition of lorazepam. Clin Pharmacol Ther (1978) 1.39

Flucloxacillin hepatitis--an Australian epidemic. Aust N Z J Med (1995) 1.38

Cimetidine spares the glucuronidation of lorazepam and oxazepam. Gastroenterology (1980) 1.33

Lidocaine in the prevention of sudden death in the pre-hospital phase of acute infarction. A double-blind study. N Engl J Med (1974) 1.29

Impact of a toxicology service on a metropolitan teaching hospital. Emerg Med (Fremantle) (2001) 1.27

Normal metabolism of morphine in cirrhosis. Gastroenterology (1981) 1.22

A decade of antibiotic use in a teaching hospital. Med J Aust (1989) 1.21

Does IL28B genotyping still have a role in the era of direct-acting antiviral therapy for chronic hepatitis C infection? J Viral Hepat (2012) 1.17

Disposition of chlordiazepoxide: sex differences and effects of oral contraceptives. Clin Pharmacol Ther (1979) 1.16

Health professionals' attitudes toward caring for people with hepatitis C. J Viral Hepat (2007) 1.14

Hepatic encephalopathy. Gastroenterology (1979) 1.13

Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures. J Neurol Neurosurg Psychiatry (1993) 1.08

Localization of uridine 5'-diphosphate-glucuronosyltransferase in human liver injury. Gastroenterology (1995) 1.06

Added value of narrow band imaging and confocal laser endomicroscopy in detecting Barrett's esophagus neoplasia. Endoscopy (2012) 1.04

The effect of food ingestion on circulating neurotensin-like immunoreactivity (NTLI) in the human. Acta Physiol Scand (1978) 1.04

Effect of cimetidine and other antihistaminics on the elimination of aminopyrine, phenacetin and caffeine. Life Sci (1980) 1.00

Prolonged effects of chronic guanethidine treatment on the sympathetic innervation of the genitalia of male rats. Med J Aust (1971) 0.98

Plasma binding of benzodiazepines in humans. J Pharm Sci (1979) 0.95

Stereoselective metabolism and disposition of the enantiomers of mephenytoin during chronic oral administration of the racemic drug in man. J Pharmacol Exp Ther (1982) 0.94

Interactions between local anesthetics and spasmogens on the guinea-pig ileum. J Pharmacol Exp Ther (1976) 0.94

Biological activity of C-terminal partial sequences of substance P. J Med Chem (1976) 0.93

Effects of cimetidine and ranitidine on hepatic drug metabolism. Clin Pharmacol Ther (1982) 0.93

A pharmacological investigation of synthetic substance P on the isolated guinea-pig ileum. Clin Exp Pharmacol Physiol (1977) 0.93

Use of a drug-screening service in an inner-city teaching hospital. Med J Aust (1981) 0.92

Hepatic extraction of morphine is impaired in cirrhosis. Eur J Clin Pharmacol (1989) 0.92

Effect of heparin administration on plasma binding of benzodiazepines. Br J Clin Pharmacol (1980) 0.91

Paracetamol self-poisoning: diagnosis, management, and outcome. Med J Aust (1982) 0.91

Diagnosis of solid pancreatic masses by endoscopic ultrasound-guided fine-needle aspiration. Intern Med J (2008) 0.89

Metoclopramide--a review. Med J Aust (1986) 0.88

Decreased oral warfarin clearance after ranitidine and cimetidine. Clin Pharmacol Ther (1984) 0.87

Endoscopic ultrasound-guided fine-needle aspiration when combined with positron emission tomography improves specificity and overall diagnostic accuracy in unexplained mediastinal lymphadenopathy and staging of non-small-cell lung cancer. Intern Med J (2008) 0.87

UDP glucuronosyltransferase in the cirrhotic rat liver. J Gastroenterol Hepatol (1996) 0.86

Incidence of antibiotic-related diarrhoea and pseudomembranous colitis: a prospective study of lincomycin, clindamycin and ampicillin. Med J Aust (1977) 0.86

Cost-effectiveness analysis of lamivudine for the treatment of chronic hepatitis B. Pharmacoeconomics (2000) 0.86

Liquid chromatographic assay for debrisoquine and 4-hydroxydebrisoquine in urine. J Chromatogr (1986) 0.86

Elimination of amphotericin B in impaired renal function. Clin Pharmacol Ther (1983) 0.86

Perspectives of paediatric and adult gastroenterologists on transfer and transition care of adolescents with inflammatory bowel disease. Intern Med J (2014) 0.86

Analysis of trimethoprim and sulphamethoxazole in human plasma by high-pressure liquid chromatography. J Chromatogr (1979) 0.85

Impaired elimination of caffeine in cirrhosis. Dig Dis Sci (1980) 0.85

The effect of hormones on the expression of five isoforms of UDP-glucuronosyltransferase in primary cultures of rat hepatocytes. Pharm Res (1999) 0.85

Determination of blood kinin levels by radioimmunoassay. Biochem Pharmacol (1972) 0.85

Blood bradykinin levels in the human. Aust J Exp Biol Med Sci (1967) 0.85

Sex hormones differentially regulate isoforms of UDP-glucuronosyltransferase. Pharm Res (1997) 0.84

A prospective study of septic complications of endoscopic retrograde cholangiopancreatography. J Gastroenterol Hepatol (1994) 0.84

Prolonged hypotension and ultrastructural changes in sympathetic neurones following guanacline treatment. Eur J Pharmacol (1971) 0.84

Bilirubin and bile acids may modulate their own metabolism via regulating uridine diphosphate-glucuronosyltransferase expression in the rat. J Gastroenterol Hepatol (2000) 0.83

The influence of liver diseases on drug disposition. Clin Gastroenterol (1979) 0.83

Regulation of uridine diphosphate glucuronosyltransferase during the acute-phase response. J Gastroenterol Hepatol (1998) 0.83

A [14C]phenacetin breath test to measure hepatic function in man. Hepatology (1984) 0.83

Possible physiological and pathological roles of the kallikrein-kinin system. Med J Aust (1972) 0.82

Development and validation of a patient-reported disability measurement tool for patients with inflammatory bowel disease. Aliment Pharmacol Ther (2012) 0.82

Absorption of orally administered amphotericin B lozenges. Br J Clin Pharmacol (1983) 0.82

Assay of flucytosine (5-fluorocytosine) in human plasma by high-pressure liquid chromatography. Antimicrob Agents Chemother (1979) 0.82

Prospective assessment of the diagnostic and therapeutic impact of small-bowel push enteroscopy. Endoscopy (2003) 0.82

Risk factors for the development of amoxycillin-clavulanic acid associated jaundice. Med J Aust (1995) 0.82

Release of neurotensin-like immunoreactivity (NTLI) from the gut in anaesthetized dogs. Acta Physiol Scand (1978) 0.82

Distribution of serotonin receptors and interacting proteins in the human sigmoid colon. Neurogastroenterol Motil (2008) 0.82

Effects of caffeine on plasma free fatty acids, urinary catecholamines, and drug binding. Clin Pharmacol Ther (1980) 0.81

Outpatient liver biopsy using ultrasound guidance and the Biopty gun is safe and cost effective. Aust N Z J Med (1995) 0.81

Surveying antibiotic use in a general teaching hospital. Med J Aust (1979) 0.81

The effects of age and chronic liver disease on the elimination of temazepam. Eur J Clin Pharmacol (1986) 0.79

Alcohol up-regulates UDP-glucuronosyltransferase mRNA expression in rat liver and in primary rat hepatocyte culture. Life Sci (2000) 0.79

THE PRESSOR EFFECT OF TYRAMINE IN MAN AND ITS MODIFICATION BY RESERPINE PRETREATMENT. J Clin Invest (1963) 0.79

The Australian method of drug-event assessment. Special workshop--regulatory. Drug Inf J (1984) 0.79

Hepatic and extrahepatic glucuronidation of lorazepam in the dog. Hepatology (1981) 0.79

The effects of metoclopramide in modifying the response of isolated guinea-pig ileum to various agonists. J Pharmacol Exp Ther (1976) 0.79

Substance P: its pharmacology and physiological roles. Aust J Exp Biol Med Sci (1977) 0.79

Expression of genes involved in lipogenesis is not increased in patients with HCV genotype 3 in human liver. J Viral Hepat (2011) 0.79

Modified trimethoprim-sulphamethoxazole doses in Pneumocystis carinii pneumonia. Lancet (1987) 0.78

Bortezomib monotherapy in patients with multiple myeloma is associated with reactivation of hepatitis B. Intern Med J (2013) 0.78

Use of prophylactic antibiotics in surgery. Med J Aust (1980) 0.78

Preservation of glucuronidation in carbon tetrachloride-induced acute liver injury in the rat. Biochem Pharmacol (1981) 0.78

Drug prescribing in hepatobiliary disease. Drugs (1979) 0.78